Draw
|
Currency :
Structure Search
AG0036VL
98319-26-7 | N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-en-17beta-carboxamide
AG0036VL
SDS
COATIP
This product is typically in stock.Please contact us for
quotation.
Request For Quotation
- mg
- g
- kg
- ml
- L
No data
- mg
- g
- kg
- ml
- L
No data
No data
| CAS Number | 98319-26-7 |
| Catalog Number | AG0036VL(AGN-PC-0W83PZ) |
| Chemical Name | N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-en-17beta-carboxamide |
| IUPAC Name | (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide |
| InChI | InChI=1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1 |
| InChI Key | DBEPLOCGEIEOCV-WSBQPABSSA-N |
| MDL Number | MFCD00869737 |
| Molecular Formula | C23H36N2O2 |
| Molecular Weight | 372.5441 |
| NSC Number | 741485 |
| SMILES | C[C@@]12[C@]([C@]3([C@@]([C@]4(C)[C@@](CC3)(NC(=O)C=C4)[H])(CC1)[H])[H])(CC[C@@H]2C(NC(C)(C)C)=O)[H] |
| UNII | 57GNO57U7G |
| Synonyms | Chibro Proscar,
Chibro-Proscar,
Eucoprost,
Finasteride,
MK 906,
MK-906,
MK906,
Propecia,
Propeshia,
Proscar,
finasteride,
98319-26-7,
Propecia,
Proscar,
Finastid,
Prostide,
Chibro-Proscar,
MK-906,
Finasterida,
Finasteridum,
Finpecia,
Finasteridum [INN-Latin],
Finasterida [INN-Spanish],
MK 906,
UNII-57GNO57U7G,
MK 0906,
MK-0906,
CCRIS 7438,
HSDB 6793,
CHEMBL710,
N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide,
BRN 4269024,
L-652,931,
(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide,
57GNO57U7G,
CHEBI:5062,
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide,
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-butyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide,
17beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androst-1-en-3-one,
C23H36N2O2,
N-(2-Methyl-2-propyl)-3-oxo-4-aza-5-alpha-androst-1-ene-17-beta-carboxamide,
Finasteride, 98%,
MFCD00869737,
4-Azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5alpha,17beta)-,
DSSTox_CID_625,
N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-en-17beta-carboxamide,
DSSTox_RID_75699,
DSSTox_GSID_20625,
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-dimethylethyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide,
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide,
Andozac,
Propecia (TN),
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-Butyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,1,
SMR000466304,
Proscar (TN),
Finasteride [USAN:INN:BAN],
N-(2-methyl-2-propyl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide,
MK906,
SR-01000759414,
NCGC00016965-01,
AK-72879,
CPD000466304,
Finasteride [USAN:USP:INN:BAN],
CAS-98319-26-7,
YM-152,
KS-1058,
Finasteride (Proscar),
AC1L1MUF,
Prestwick0_000717,
Prestwick1_000717,
Prestwick2_000717,
Prestwick3_000717,
AC1Q5L2C,
SCHEMBL5509,
BSPBio_000933,
MLS000759404,
MLS001165768,
MLS001424046,
Finasteride (JAN/USP/INN),
SPBio_002854,
BPBio1_001027,
GTPL6818,
DTXSID3020625,
DBEPLOCGEIEOCV-WSBQPABSSA-N,
BCPP000229,
HMS1570O15,
HMS2051F09,
HMS2090G22,
HMS2097O15,
HMS2235L23,
HMS3714O15,
4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide,
ACT02599,
EX-A1951,
ZINC3782599,
Tox21_110717,
Tox21_201506,
Tox21_302744,
AN-615,
BDBM50334788,
NSC741485,
s1197,
AKOS015894916,
Tox21_110717_1,
AB07586,
BCP9000685,
CCG-100937,
CS-1767,
DB01216,
Finasteride, >=98% (HPLC), powder,
LS-7397,
NC00187,
NSC-741485,
NCGC00093560-05,
NCGC00256334-01,
NCGC00259057-01,
AJ-45596,
BC200264,
BR-72879,
CC-28426,
HY-13635,
SC-12178,
BCP0726000222,
AB1008360,
ST2419391,
AB00513901,
FT-0082891,
D00321,
J10122,
X-2990,
32329-EP2272827A1,
32329-EP2275420A1,
32329-EP2280012A2,
32329-EP2281815A1,
32329-EP2292615A1,
32329-EP2295055A2,
32329-EP2295416A2,
32329-EP2295426A1,
32329-EP2295427A1,
32329-EP2298748A2,
32329-EP2298764A1,
32329-EP2298765A1,
32329-EP2298768A1,
32329-EP2301928A1,
32329-EP2301933A1,
32329-EP2305640A2,
32329-EP2305642A2,
32329-EP2305671A1,
32329-EP2311453A1,
32329-EP2311808A1,
32329-EP2311825A1,
32329-EP2311827A1,
32329-EP2311829A1,
32329-EP2311840A1,
AB00513901-07,
AB00513901-08,
AB00513901_09,
Finasteride, VETRANAL(TM), analytical standard,
319F267,
C-34893,
SR-01000759414-4,
SR-01000759414-6,
BRD-K01095011-001-03-5,
BRD-K01095011-001-15-9,
Finasteride, British Pharmacopoeia (BP) Reference Standard,
Finasteride, European Pharmacopoeia (EP) Reference Standard,
(17beta-(N-tert-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one,
Finasteride, United States Pharmacopeia (USP) Reference Standard,
4-azaandrost-1-ene-17-carboxamide, N -(1,1-dimethylethyl)-3-oxo-,(5(alpha),17(beta))-,
4-azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5alpha, 17beta)-,
4-Azaandrost-1-ene-17-carboxamide,1-dimethylethyl)-3-oxo-, (5.alpha., 17.beta.)-,
Finasteride for peak identification, European Pharmacopoeia (EP) Reference Standard,
(1S,2R,7R,10S,11S,14S,15S)-N-tert-butyl-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-3-ene-14-carboxamide,
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-isobutyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide,
(4AR,4BS,6AS,7S,9AS,9BS,11AR)-4A,6A-DIMETHYL-2-OXO-2,4A,4B,5,6,6A,7,8,9,9A,9B,10,11,11A-TETRADECAHYDRO-1H-INDENO[5,4-F]QUINOLINE-7-CARBOXYLIC ACID TERT-BUTYLAMIDE,
(4aR,4bS,6aS,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide,
(4aR,6aS)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide,
(4aR,6aS,11aR)-4a,6a-Dimethyl-2-oxo-hexadecahydro-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide,
(4aR,6aS,7S)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide,
(4aR,6aS,7S,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide,
(R)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide,
4a,6a,9a-Trimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid (Finasteride),
4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide(Finasteride),
N-tert-Butyl-3-oxo-4-aza-5|A-androst-1-en-17|A-carboxamide; N-(2-Methyl-2-propyl)-3-oxo-4-aza-5|A-androst-1-ene-17|A-carboxamide,
Prosteride,
Eucoprost,
Propeshia,
Chibro Proscar,
Fistide,
Finara,
Finast,
Fincar,
Prodel,
Finax,
Finasterid (TN),
Prosteride (TN),
Alternova (TN),
Finpecia (TN),
Appecia (TN),
Finalo (TN),
Finara (TN),
Finast (TN),
Fincar (TN),
Gefina (TN),
Finax (TN),
Finasterid IVAX (TN),
Finasteride (USP/INN),
MSD Brand of Finasteride,
D08IWD,
Lipha Brand of Finasteride,
Merck Brand 1 of Finasteride,
Merck Brand 2 of Finasteride,
Finasteride [USAN:BAN:INN],
Proscar, Propecia, Finasteride,
CID57363,
Frosst Iberica Brand of Finasteride,
Merck Frosst Brand 1 of Finasteride,
Merck Frosst Brand 2 of Finasteride,
MSD Chibropharm Brand of Finasteride,
C23-H36-N2-O2,
ACN-043358,
CS-O-00611,
Cahill May Roberts Brand of Finasteride,
A5143,
Merck Sharp & Dhome Brand 2 of Finasteride,
Merck Sharp & Dohme Brand 1 of Finasteride,
D018120,
17b-(tert-Butylcarbamoyl)-4-aza-5a-androsten-3-one,
17-beta-(N-tert-butylcarbamoyl)-4-aza-5-alpha-androst-1-en-3-one,
FIT,
Finasteride, 98%, an orally active testosterone 5-alpha-reductase inhibitor - 1G 1g,
166896-74-8,
1h-indeno[5,4-f]quinolina-7-carboxamida, n-(1,1-dimetiletil)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahidro-4a,6a-dimetil-2-oxo-, (4ar,4bs,6as,7s,9as,9bs,11ar)-,
|
| Complexity | 678 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 7 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 372.278g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 27 |
| Hydrogen Bond Acceptor Count | 2 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 372.553g/mol |
| Monoisotopic Mass | 372.278g/mol |
| Rotatable Bond Count | 2 |
| Topological Polar Surface Area | 58.2A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3 |
GHS Hazard and Precautionary Statements
| Symbol: |  |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
Certificate of Analysis
Lot Number
Related Research Chemicals
CERTIFICATE OF ANALYSIS
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
Analysis Data:
| Test: | Result: |
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited